New Stock Screens Highlight Growth, Dividend, and Speculative Australian and Asian Opportunities

Gold Fields’ rejected proposal for Northern Star valued it at A$38.7 billion and offered A$7.25 in cash plus 0.3125 Gold Fields shares for each Northern Star share. Elliott Investment Management had also raised its Northern Star stake to 6.24%.
Starpharma’s growth case is tied to its DEP oncology platform, with profitability forecast within three years; the article also notes index inclusions and fresh equity funding as sources of visibility and runway, while flagging an unresolved clinical and commercial hurdle.
Objective Corporation’s dividend appeal is linked to recurring, contract-driven revenue from government and regulated clients. The article puts its software revenue at about A$135 million and its market value at roughly A$575 million.
AIC Mines recorded 177.3% earnings growth over the past year, while forecast revenue growth is about 19.5% annually; the article says its outlook is supported by copper and gold production plans.
The Asian growth-stock screener article says Smoore International’s first-half 2026 sales rose to CNY 7.21 billion and net income reached CNY 571.92 million. It also cautions that dividend sustainability is a concern and notes no recent insider trading activity.
Australian stock analysts are flagging a mixed bag of opportunities across the ASX, from mega-cap shifts to penny-stock bets. Yahoo Finance coverage spans major analyst calls on ASX stalwarts alongside screeners hunting smaller growth, income, and speculative plays. The picks reflect divergent strategies — some betting on established names like Megaport and Northern Star Resources, others hunting diamonds in riskier corners of the market.
Gold Fields' unsolicited proposal valued Northern Star Resources at A$38.7 billion, offering A$7.25 in cash plus 0.3125 Gold Fields shares per share. Northern Star's board rejected the deal, and analysts recommend holding the stock while events unfold. Yahoo Finance notes that Elliott Investment Management had already built a 6.24% stake, signaling activist pressure on the company.
Analysts upgraded Megaport on stronger guidance and growing AI infrastructure contracts. The data-center connectivity play benefits from rising demand for server capacity and cloud buildout. Yahoo Finance screeners flag it as a core holding in growth-focused portfolios, even as broader market uncertainty persists.
Objective Corporation attracts dividend hunters with recurring, contract-driven revenue from government and regulated clients. Yahoo Finance values the software firm at roughly A$575 million with annual revenue near A$135 million. Vita Life Sciences also appears on income-focused screens, though both require monitoring for revenue stability and regulatory shifts.
AIC Mines recorded 177.3% earnings growth over the past year, backed by copper and gold production ramps with forecast revenue growth around 19.5% annually. Yahoo Finance also flags Alkane Resources as a speculative small-cap bet. These volatile picks suit risk-tolerant investors hunting outsized returns, but lack the balance-sheet cushion of larger peers.
Starpharma's bullish thesis rests on its DEP oncology platform, expected to reach profitability within three years. Yahoo Finance notes that index inclusions and fresh equity funding provide visibility and runway, but an unresolved clinical and commercial hurdle remains a risk. The biotech play suits growth accounts willing to tolerate clinical trial delays and setbacks.
Publishers
23
Articles
28
Reach
51